설명

Analysis of DNMT1 protein levels and activity in prostate cancer cells treated with melatonin, showing how SIRT1-mediated deacetylation reduces DNMT1 function.

Figure 23

Chart

Source Paper

Melatonin inhibits lipid accumulation to repress prostate cancer progression by mediating the epigenetic modification of CES1.

Clinical and translational medicine (2021)

PMID: 34185414

DOI: 10.1002/ctm2.449

Cite This Figure

![Figure 23: Analysis of DNMT1 protein levels and activity in prostate cancer cells treated with melatonin, showing how SIRT1-mediated deacetylation reduces DNMT1 function.]()

> Source: Lijie Zhou et al. "Melatonin inhibits lipid accumulation to repress prostate cancer progression by ." *Clinical and translational medicine*, 2021. PMID: [34185414](https://pubmed.ncbi.nlm.nih.gov/34185414/)

<figure>
  <img src="" alt="Analysis of DNMT1 protein levels and activity in prostate cancer cells treated with melatonin, showing how SIRT1-mediated deacetylation reduces DNMT1 function." />
  <figcaption>Figure 23. Analysis of DNMT1 protein levels and activity in prostate cancer cells treated with melatonin, showing how SIRT1-mediated deacetylation reduces DNMT1 function.<br>  Source: Lijie Zhou et al. "Melatonin inhibits lipid accumulation to repress prostate cancer progression by ." <em>Clinical and translational medicine</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34185414/">34185414</a></figcaption>
</figure>

설명

Figure 23

Source Paper

Cite This Figure

관련 근거